These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19226162)

  • 21. Docking ligands into flexible and solvated macromolecules. 2. Development and application of fitted 1.5 to the virtual screening of potential HCV polymerase inhibitors.
    Corbeil CR; Englebienne P; Yannopoulos CG; Chan L; Das SK; Bilimoria D; L'heureux L; Moitessier N
    J Chem Inf Model; 2008 Apr; 48(4):902-9. PubMed ID: 18341269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A highly efficient, asymmetric synthesis of benzothiadiazine-substituted tetramic acids: potent inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
    Fitch DM; Evans KA; Chai D; Duffy KJ
    Org Lett; 2005 Nov; 7(24):5521-4. PubMed ID: 16288546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5,6-Dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase.
    Ruebsam F; Tran CV; Li LS; Kim SH; Xiang AX; Zhou Y; Blazel JK; Sun Z; Dragovich PS; Zhao J; McGuire HM; Murphy DE; Tran MT; Stankovic N; Ellis DA; Gobbi A; Showalter RE; Webber SE; Shah AM; Tsan M; Patel RA; Lebrun LA; Hou HJ; Kamran R; Sergeeva MV; Bartkowski DM; Nolan TG; Norris DA; Kirkovsky L
    Bioorg Med Chem Lett; 2009 Jan; 19(2):451-8. PubMed ID: 19054673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Valopicitabine dihydrochloride:a specific polymerase inhibitor of hepatitis C virus.
    Toniutto P; Fabris C; Bitetto D; Fornasiere E; Rapetti R; Pirisi M
    Curr Opin Investig Drugs; 2007 Feb; 8(2):150-8. PubMed ID: 17328231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second generation of hydroxyethylamine BACE-1 inhibitors: optimizing potency and oral bioavailability.
    Charrier N; Clarke B; Cutler L; Demont E; Dingwall C; Dunsdon R; East P; Hawkins J; Howes C; Hussain I; Jeffrey P; Maile G; Matico R; Mosley J; Naylor A; O'Brien A; Redshaw S; Rowland P; Soleil V; Smith KJ; Sweitzer S; Theobald P; Vesey D; Walter DS; Wayne G
    J Med Chem; 2008 Jun; 51(11):3313-7. PubMed ID: 18457381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-1-benzyl and N-1-[3-methylbutyl]-4-hydroxy-1,8-naphthyridon-3-yl benzothiadiazine analogs containing substituents on the aromatic ring.
    Rockway TW; Zhang R; Liu D; Betebenner DA; McDaniel KF; Pratt JK; Beno D; Montgomery D; Jiang WW; Masse S; Kati WM; Middleton T; Molla A; Maring CJ; Kempf DJ
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3833-8. PubMed ID: 16650984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of 1'-C-cyano pyrimidine nucleosides and characterization as HCV polymerase inhibitors.
    Kirschberg TA; Mish M; Squires NH; Zonte S; Aktoudianakis E; Metobo S; Butler T; Ju X; Cho A; Ray AS; Kim CU
    Nucleosides Nucleotides Nucleic Acids; 2015; 34(11):763-85. PubMed ID: 26398773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and structure-activity relationships of dehydroaltenusin derivatives as selective DNA polymerase alpha inhibitors.
    Kuramochi K; Fukudome K; Kuriyama I; Takeuchi T; Sato Y; Kamisuki S; Tsubaki K; Sugawara F; Yoshida H; Mizushina Y
    Bioorg Med Chem; 2009 Oct; 17(20):7227-38. PubMed ID: 19767211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3D-QSAR and docking studies on a series of benzothiadiazine derivatives as genotype 1 HCV polymerase inhibitors.
    Patil VM; Gupta SP; Samanta S; Masand N
    Med Chem; 2012 Nov; 8(6):1099-107. PubMed ID: 22779799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, DNA-binding ability and evaluation of antitumour activity of triazolo[1,2,4]benzothiadiazine linked pyrrolo[2,1-c][1,4]benzodiazepine conjugates.
    Kamal A; Khan MN; Srikanth YV; Reddy KS; Juvekar A; Sen S; Kurian N; Zingde S
    Bioorg Med Chem; 2008 Aug; 16(16):7804-10. PubMed ID: 18657979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-nucleoside analogue polymerase inhibitors in development.
    Pockros PJ
    Clin Liver Dis; 2013 Feb; 17(1):123-8. PubMed ID: 23177288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and Biological Characterization of Aryl Uracil Inhibitors of Hepatitis C Virus NS5B Polymerase: Discovery of ABT-072, a trans-Stilbene Analog with Good Oral Bioavailability.
    Randolph JT; Krueger AC; Donner PL; Pratt JK; Liu D; Motter CE; Rockway TW; Tufano MD; Wagner R; Lim HB; Beyer JM; Mondal R; Panchal NS; Colletti L; Liu Y; Koev G; Kati WM; Hernandez LE; Beno DWA; Longenecker KL; Stewart KD; Dumas EO; Molla A; Maring CJ
    J Med Chem; 2018 Feb; 61(3):1153-1163. PubMed ID: 29342358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toward the back-up of boceprevir (SCH 503034): discovery of new extended P4-capped ketoamide inhibitors of hepatitis C virus NS3 serine protease with improved potency and pharmacokinetic profiles.
    Bogen SL; Pan W; Ruan S; Nair LG; Arasappan A; Bennett F; Chen KX; Jao E; Venkatraman S; Vibulbhan B; Liu R; Cheng KC; Guo Z; Tong X; Saksena AK; Girijavallabhan V; Njoroge FG
    J Med Chem; 2009 Jun; 52(12):3679-88. PubMed ID: 19456105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and evaluation of ATP-binding site directed potential inhibitors of nucleoside triphosphatases/helicases and polymerases of hepatitis C and other selected Flaviviridae viruses.
    Bretner M; Schalinski S; Haag A; Lang M; Schmitz H; Baier A; Behrens SE; Kulikowski T; Borowski P
    Antivir Chem Chemother; 2004 Jan; 15(1):35-42. PubMed ID: 15074713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C NS5B polymerase inhibitors: functional equivalents for the benzothiadiazine moiety.
    Hutchinson DK; Flentge CA; Donner PL; Wagner R; Maring CJ; Kati WM; Liu Y; Masse SV; Middleton T; Mo H; Montgomery D; Jiang WW; Koev G; Beno DW; Stewart KD; Stoll VS; Molla A; Kempf DJ
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1876-9. PubMed ID: 21316235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitors of hepatitis C virus NS3/4A: alpha-ketoamide based macrocyclic inhibitors.
    Avolio S; Robertson K; Hernando JI; DiMuzio J; Summa V
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2295-8. PubMed ID: 19285390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modification of hepatitis C virus 1b RNA polymerase to make a highly active JFH1-type polymerase by mutation of the thumb domain.
    Weng L; Du J; Zhou J; Ding J; Wakita T; Kohara M; Toyoda T
    Arch Virol; 2009; 154(5):765-73. PubMed ID: 19340394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel macrocyclic inhibitors of hepatitis C NS3/4A protease featuring a 2-amino-1,3-thiazole as a P4 carbamate replacement.
    Di Francesco ME; Dessole G; Nizi E; Pace P; Koch U; Fiore F; Pesci S; Di Muzio J; Monteagudo E; Rowley M; Summa V
    J Med Chem; 2009 Nov; 52(22):7014-28. PubMed ID: 19856919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver-targeted prodrugs of 2'-C-methyladenosine for therapy of hepatitis C virus infection.
    Hecker SJ; Reddy KR; van Poelje PD; Sun Z; Huang W; Varkhedkar V; Reddy MV; Fujitaki JM; Olsen DB; Koeplinger KA; Boyer SH; Linemeyer DL; MacCoss M; Erion MD
    J Med Chem; 2007 Aug; 50(16):3891-6. PubMed ID: 17636948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-based discovery of triphenylmethane derivatives as inhibitors of hepatitis C virus helicase.
    Chen CS; Chiou CT; Chen GS; Chen SC; Hu CY; Chi WK; Chu YD; Hwang LH; Chen PJ; Chen DS; Liaw SH; Chern JW
    J Med Chem; 2009 May; 52(9):2716-23. PubMed ID: 19419203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.